• 10058-F4 C-Myc-Max Dimerization Inhibitor: Precision Tools f

  2026-06-16

  Explore how the 10058-F4 c-Myc-Max dimerization inhibitor uniquely modulates transcription factor activity and telomerase regulation. This in-depth analysis introduces fresh perspectives on apoptosis, AML, prostate cancer models, and practical protocol optimization.

• HyperScribe SP6 High Yield RNA Synthesis Kit: Precision RNA

  2026-06-16

  The HyperScribe SP6 High Yield RNA Synthesis Kit delivers unmatched speed and flexibility for capped, biotinylated, and radiolabeled RNA production. Its robust protocol enables high-yield synthesis crucial for RNA vaccine research, probe development, and advanced RNAi studies, setting a new benchmark for reliable, modification-ready transcripts.

• HotStart Universal 2X Green qPCR Master Mix: Mechanism & Evi

  2026-06-15

  HotStart Universal 2X Green qPCR Master Mix enables precise, reproducible gene expression quantification via a hot-start Taq polymerase and Green I dye. Its robust specificity and ROX compatibility minimize non-specific amplification and instrument variance. This dossier details its validated performance and best-practice workflow.

• 2-NBDG Glucose Uptake Assay Kit: Advanced Cellular Metabolis

  2026-06-15

  The 2-NBDG Glucose Uptake Assay Kit offers researchers a sensitive, non-radioactive method for quantifying glucose uptake at the single-cell level, critical for dissecting metabolic pathways in cancer and diabetes. Its optimized workflow, specificity controls, and fluorescence-based readout set a new standard for metabolic research and troubleshooting.

• YTHDF1 Phase Separation Directs SSC Fate via IkB-NF-kB-CCND1

  2026-06-14

  Fang et al. (2023) elucidate how the liquid-liquid phase separation (LLPS) of YTHDF1, an m6A reader protein, orchestrates the transition of spermatogonial stem cells into neural stem cell-like cells by modulating the IkB-NF-kB-CCND1 pathway. These findings provide mechanistic insight into protein-RNA LLPS as a regulator of cell fate, with significant implications for regenerative medicine and translational neuroscience.

• Talabostat Mesylate: Applied Workflows in Tumor Microenviron

  2026-06-13

  Talabostat mesylate (PT-100) redefines experimental approaches in tumor microenvironment and immunology research by specifically inhibiting DPP4 and FAP. This article delivers actionable, evidence-backed workflows, troubleshooting strategies, and recent advances from CARD8 inflammasome studies to maximize data impact and experimental reproducibility.

• 1-Phenyl-2-Pentanol from Moringa Inhibits Hepatic Stellate A

  2026-06-12

  This study identifies 1-phenyl-2-pentanol (1-PHE), isolated from Moringa oleifera leaves, as a novel inhibitor of hepatic stellate cell (HSC) activation in vitro. By suppressing TGF-β1 and Wnt/β-catenin signaling, 1-PHE demonstrates anti-fibrotic potential, offering mechanistic insight and a new direction for liver fibrosis research.

• Cy3 NHS ester (non-sulfonated): Technical Guide & Workflow Q

  2026-06-12

  Cy3 NHS ester (non-sulfonated) is designed for efficient fluorescent labeling of amino-containing biomolecules in protein, peptide, and oligonucleotide applications requiring organic co-solvents. It excels in workflows compatible with DMSO or DMF, offering high sensitivity in imaging and detection. It should not be used in protocols requiring strictly aqueous conditions or long-term storage of dye solutions.

• Unleashing Dual-Mode mRNA Reporters: Mechanisms & Strategy

  2026-06-11

  Explore how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) redefines translational research through dual-modality imaging, immune evasion, and advanced mRNA delivery. This article integrates mechanistic insights, peer-reviewed competitive benchmarking, and actionable guidance for researchers navigating the evolving mRNA landscape.

• SGC-CBP30: Precision CREBBP/EP300 Inhibition in Epigenetics

  2026-06-11

  Explore SGC-CBP30 as a powerful CREBBP/EP300 bromodomain inhibitor for advanced epigenetics research. This article uniquely dissects its mechanistic advantages, assay optimization, and critical application in cancer biology beyond existing content.

• Bsa I (RNase-free): Technical Guide for Precise DNA Cleavage

  2026-06-10

  Bsa I (RNase-free) enables precise DNA cleavage while minimizing RNA degradation, making it well-suited for sensitive molecular biology research such as gene cloning and DNA recombinant technology. Its RNase-free formulation ensures RNA preservation during workflows where RNA integrity is critical. This product is not intended for diagnostic or clinical applications.

• mCherry mRNA for Robust Fluorescent Protein Expression Workf

  2026-06-10

  EZ Cap™ mCherry mRNA (5mCTP, ψUTP) empowers researchers to achieve vivid, reproducible red fluorescence with minimized immune activation, thanks to its Cap 1 structure and advanced modifications. APExBIO’s product stands out for rapid cell labeling, exceptional mRNA stability, and seamless integration with lipid nanoparticle delivery, setting a new benchmark for reporter gene assays and live-cell imaging.

• Solving Glucose Uptake Assay Challenges with 2-NBDG Kit (K22

  2026-06-09

  This article delivers a scenario-driven, evidence-based overview of the 2-NBDG Glucose Uptake Assay Kit (SKU K2212) for biomedical researchers. It explores real laboratory challenges in glucose metabolism research and demonstrates how the kit's fluorescence-based workflow, specificity controls, and high-throughput compatibility enhance data reproducibility and usability, supporting advanced applications in cancer and diabetes metabolism studies.

• Glycogen Colorimetric Assay Kit II: Precision in Circadian M

  2026-06-09

  Explore how the Glycogen Colorimetric Assay Kit II enables precise, interference-resistant quantification of glycogen, uniquely empowering circadian metabolism and exercise adaptation research. Delve into advanced assay mechanisms, protocol optimization, and recent discoveries in time-of-day–dependent glycogen dynamics.

• Dual-Action Kinase Inhibitors Enhance p38α MAPK Dephosphoryl

  2026-06-08

  This study demonstrates that certain kinase inhibitors can both inhibit p38α MAPK activity and promote its dephosphorylation by phosphatases, revealing a dual-action mechanism. These findings provide a new strategy to enhance specificity and potency in inflammation and vascular research by leveraging conformational control of kinase targets.

775 records 15/52 page Previous Next First page 上5页 1112131415 下5页 Last page